Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 257–257 | Cite as

Nivolumab

Checkpoint inhibitor pneumonitis: case report
Case report
  • 4 Downloads

Reference

  1. Yoshida K, et al. Serum Soluble Interleukin-2 Receptor as a Possible Biomarker for the Early Detection and Follow-up of Nivolumab-Induced Pneumonitis. Journal of Thoracic Oncology 14: e90-e91, No. 5, May 2019. Available from: URL: http://doi.org/10.1016/j.jtho.2018.12.028 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations